Jacqueline Zayas1, Kathryn J Ruddy2, Janet E Olson3, Fergus J Couch4, Brent A Bauer5, Molly J Mallory5, Ping Yang3, David Zahrieh3, Arjun P Athreya6, Charles L Loprinzi2, Elizabeth J Cathcart-Rake2. 1. Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Medicine and the Mayo Clinic Medical Scientist Training Program, Rochester, MN, 55905, USA. Zayas.jacqueline@mayo.edu. 2. Department of Medical Oncology, Mayo Clinic, Rochester, MN, 55905, USA. 3. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA. 4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. 5. Department of General Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA. 6. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Abstract
PURPOSE: The purpose of this study was to evaluate acupuncture use among breast cancer survivors, including perceived symptom improvements and referral patterns. METHODS: Breast cancer survivors who had used acupuncture for cancer- or treatment-related symptoms were identified using an ongoing prospective Mayo Clinic Breast Disease Registry (MCBDR). Additionally, Mayo Clinic electronic health records (MCEHR) were queried to identify eligible participants. All received a mailed consent form and survey including acupuncture-related questions about acupuncture referrals, delivery, and costs. Respondents were also asked to recall symptom severity before and after acupuncture treatment and time to benefit on Likert scales. RESULTS: Acupuncture use was reported among 415 participants (12.3%) of the MCBDR. Among MCBDR and MCEHR eligible participants, 241 women returned surveys. A total of 193 (82.1%) participants reported a symptomatic benefit from acupuncture, and 57 (24.1% of participants) reported a "substantial benefit" or "totally resolved my symptoms" (corresponding to 4 and 5 on the 5-point Likert scale). The mean symptom severity decreased by at least 1 point of the 5-point scale for each symptom; the percentage of patients who reported an improvement in symptoms ranged from 56% (lymphedema) to 79% (headache). The majority of patients reported time to benefit as "immediate" (34%) or "after a few treatments" (40.4%). Over half of the participants self-referred for treatment; 24.1% were referred by their oncologist. Acupuncture delivery was more frequent in private offices (61.0%) than in hospital or medical settings (42.3%). Twelve participants (5.1%) reported negative side effects, such as discomfort. CONCLUSIONS: Acupuncture is commonly utilized by patients for a variety of breast cancer-related symptoms. However, patients frequently self-refer for acupuncture treatments, and most acupuncture care is completed at private offices, rather than medical clinic or hospital settings.
PURPOSE: The purpose of this study was to evaluate acupuncture use among breast cancer survivors, including perceived symptom improvements and referral patterns. METHODS:Breast cancer survivors who had used acupuncture for cancer- or treatment-related symptoms were identified using an ongoing prospective Mayo Clinic Breast Disease Registry (MCBDR). Additionally, Mayo Clinic electronic health records (MCEHR) were queried to identify eligible participants. All received a mailed consent form and survey including acupuncture-related questions about acupuncture referrals, delivery, and costs. Respondents were also asked to recall symptom severity before and after acupuncture treatment and time to benefit on Likert scales. RESULTS: Acupuncture use was reported among 415 participants (12.3%) of the MCBDR. Among MCBDR and MCEHR eligible participants, 241 women returned surveys. A total of 193 (82.1%) participants reported a symptomatic benefit from acupuncture, and 57 (24.1% of participants) reported a "substantial benefit" or "totally resolved my symptoms" (corresponding to 4 and 5 on the 5-point Likert scale). The mean symptom severity decreased by at least 1 point of the 5-point scale for each symptom; the percentage of patients who reported an improvement in symptoms ranged from 56% (lymphedema) to 79% (headache). The majority of patients reported time to benefit as "immediate" (34%) or "after a few treatments" (40.4%). Over half of the participants self-referred for treatment; 24.1% were referred by their oncologist. Acupuncture delivery was more frequent in private offices (61.0%) than in hospital or medical settings (42.3%). Twelve participants (5.1%) reported negative side effects, such as discomfort. CONCLUSIONS: Acupuncture is commonly utilized by patients for a variety of breast cancer-related symptoms. However, patients frequently self-refer for acupuncture treatments, and most acupuncture care is completed at private offices, rather than medical clinic or hospital settings.
Entities:
Keywords:
Acupuncture; Breast cancer; Complementary and alternative medicine; Survivorship
Authors: Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam Journal: J Cancer Surviv Date: 2010-10-06 Impact factor: 4.442
Authors: Jon C Tilburt; Franklin G Miller; Sarah Jenkins; Ted J Kaptchuk; Brian Clarridge; Dragana Bolcic-Jankovic; Ezekiel J Emanuel; Farr A Curlin Journal: Med Care Date: 2010-04 Impact factor: 2.983
Authors: Farah Z Zia; Oluwadamilola Olaku; Ting Bao; Ann Berger; Gary Deng; Arthur Yin Fan; Mary K Garcia; Patricia M Herman; Ted J Kaptchuk; Elena J Ladas; Helene M Langevin; Lixing Lao; Weidong Lu; Vitaly Napadow; Richard C Niemtzow; Andrew J Vickers; Xin Shelley Wang; Claudia M Witt; Jun J Mao Journal: J Natl Cancer Inst Monogr Date: 2017-11-01
Authors: Ting Bao; Olga Goloubeva; Colleen Pelser; Neil Porter; James Primrose; Lisa Hester; Mariola Sadowska; Rena Lapidus; Michelle Medeiros; Lixing Lao; Susan G Dorsey; Ashraf Z Badros Journal: Integr Cancer Ther Date: 2014-05-26 Impact factor: 3.279
Authors: M Kay Garcia; Lorenzo Cohen; Ying Guo; Yuhong Zhou; Bing You; Joseph Chiang; Robert Z Orlowski; Donna Weber; Jatin Shah; Raymond Alexanian; Sheeba Thomas; Jorge Romaguera; Liang Zhang; Maria Badillo; Yiming Chen; Qi Wei; Richard Lee; Kay Delasalle; Vivian Green; Michael Wang Journal: J Hematol Oncol Date: 2014-05-09 Impact factor: 17.388